GLP-1 Research
Semaglutide, the drug behind Ozempic, has demonstrated clinically significant benefits for cardiovascular disease, liver disease, kidney protection, addiction,…
GLP-1 medications produce real weight loss, but stopping them triggers measurable regain — here's what the science says…
Ozempic's clinical evidence for type 2 diabetes management is robust, but understanding the real risks, contraindications, and how…
A complete, evidence-based guide to Ozempic injection technique, dose escalation, site rotation, storage, and the clinical science behind…
Research shows up to 45% of weight lost on semaglutide can come from skeletal muscle — here's what…
A science-backed breakdown of the Ozempic dose increase schedule — why the titration protocol exists, what happens at…
Research shows semaglutide can cause significant muscle loss equivalent to over a decade of aging — here's what…
Semaglutide begins affecting blood glucose and appetite within weeks, but meaningful fat loss typically emerges between weeks 8…
GLP-1 is a gut hormone that regulates insulin, appetite, and blood sugar — and understanding how it works…
A science-backed breakdown of how GLP-1 receptor agonists reduce cardiovascular events, protect kidney function, and address liver disease…